Published in AIDS Behav on October 01, 2014
Health behavior change models for HIV prevention and AIDS care: practical recommendations for a multi-level approach. J Acquir Immune Defic Syndr (2014) 0.97
Big Events in Greece and HIV Infection Among People Who Inject Drugs. Subst Use Misuse (2015) 0.94
A new approach to prevent HIV transmission: Project Protect intervention for recently infected individuals. AIDS Care (2014) 0.81
Prevention of early HIV transmissions might be more important in emerging or generalizing epidemics. Proc Natl Acad Sci U S A (2015) 0.80
Network Characteristics of People Who Inject Drugs Within a New HIV Epidemic Following Austerity in Athens, Greece. J Acquir Immune Defic Syndr (2015) 0.78
"Integrated interventions are dead. Long live sustainable integrated interventions!"--Austerity Challenges the Continuation of Effective Interventions in the Field of Drug Use-Related Harm Reduction. Subst Use Misuse (2015) 0.75
A network intervention that locates and intervenes with recently HIV-infected persons: The Transmission Reduction Intervention Project (TRIP). Sci Rep (2016) 0.75
Acute HIV infection transmission among people who inject drugs in a mature epidemic setting. AIDS (2016) 0.75
Accuracy of name and age data provided about network members in a social network study of people who use drugs: implications for constructing sociometric networks. Ann Epidemiol (2016) 0.75
Suboptimal HIV Testing Uptake Among Men Who Engage in Commercial Sex Work with Men in Asia. LGBT Health (2016) 0.75
Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med (2011) 69.36
The Health Belief Model: a decade later. Health Educ Q (1984) 25.48
Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis (2005) 21.08
Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med (2009) 19.90
The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis (2011) 16.88
High rates of forward transmission events after acute/early HIV-1 infection. J Infect Dis (2007) 7.70
Behavioural strategies to reduce HIV transmission: how to make them work better. Lancet (2008) 7.42
Vital signs: HIV prevention through care and treatment--United States. MMWR Morb Mortal Wkly Rep (2011) 6.90
HIV-1 transmission, by stage of infection. J Infect Dis (2008) 6.57
Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study. PLoS Pathog (2013) 6.14
Acute HIV-1 Infection. N Engl J Med (2011) 4.84
Short-course antiretroviral therapy in primary HIV infection. N Engl J Med (2013) 4.82
Episodic sexual transmission of HIV revealed by molecular phylodynamics. PLoS Med (2008) 4.76
HIV surveillance--United States, 1981-2008. MMWR Morb Mortal Wkly Rep (2011) 4.30
HIV prevention transformed: the new prevention research agenda. Lancet (2011) 4.23
Better physician-patient relationships are associated with higher reported adherence to antiretroviral therapy in patients with HIV infection. J Gen Intern Med (2004) 4.17
The state of engagement in HIV care in the United States: from cascade to continuum to control. Clin Infect Dis (2013) 4.04
Structural factors in HIV prevention: concepts, examples, and implications for research. AIDS (2000) 3.97
Lay health advisor interventions among Hispanics/Latinos: a qualitative systematic review. Am J Prev Med (2007) 3.69
Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature. J Acquir Immune Defic Syndr (2002) 3.55
The Sonagachi Project: a sustainable community intervention program. AIDS Educ Prev (2004) 3.54
Risk factors, barriers and facilitators for linkage to antiretroviral therapy care: a systematic review. AIDS (2012) 3.50
Entry and retention in medical care among HIV-diagnosed persons: a meta-analysis. AIDS (2010) 3.44
Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy. Clin Infect Dis (2009) 3.30
Sociometric risk networks and risk for HIV infection. Am J Public Health (1997) 3.29
Social network dynamics and HIV transmission. AIDS (1998) 3.14
Determinants of per-coital-act HIV-1 infectivity among African HIV-1-serodiscordant couples. J Infect Dis (2012) 3.06
HIV System Navigation: an emerging model to improve HIV care access. AIDS Patient Care STDS (2007) 3.02
Network-related mechanisms may help explain long-term HIV-1 seroprevalence levels that remain high but do not approach population-group saturation. Am J Epidemiol (2000) 2.95
"Informed altruism" and "partner restriction" in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990-2001. J Acquir Immune Defic Syndr (2004) 2.90
Combination HIV prevention: significance, challenges, and opportunities. Curr HIV/AIDS Rep (2011) 2.72
Antiretroviral adherence interventions: a review of current literature and ongoing studies. Top HIV Med (2004) 2.64
Effect of treating co-infections on HIV-1 viral load: a systematic review. Lancet Infect Dis (2010) 2.60
HIV-1 outbreak among injecting drug users in Greece, 2011: a preliminary report. Euro Surveill (2011) 2.42
Detection of recent HIV-1 infection using a new limiting-antigen avidity assay: potential for HIV-1 incidence estimates and avidity maturation studies. PLoS One (2012) 2.41
Effect of directly observed therapy for highly active antiretroviral therapy on virologic, immunologic, and adherence outcomes: a meta-analysis and systematic review. J Acquir Immune Defic Syndr (2010) 2.36
Urging others to be healthy: "intravention" by injection drug users as a community prevention goal. AIDS Educ Prev (2004) 2.31
The detection of acute HIV infection. J Infect Dis (2010) 2.14
"Getting me back on track": the role of outreach interventions in engaging and retaining people living with HIV/AIDS in medical care. AIDS Patient Care STDS (2007) 2.09
Cluster of cases of the acquired immune deficiency syndrome. Patients linked by sexual contact. Am J Med (1984) 2.08
Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America. Clin Infect Dis (2009) 2.05
Building community-engaged health research and discovery infrastructure on the South Side of Chicago: science in service to community priorities. Prev Med (2011) 2.01
Structural and social contexts of HIV risk Among African Americans. Am J Public Health (2009) 2.00
HIV among Black men who have sex with men (MSM) in the United States: a review of the literature. AIDS Behav (2014) 1.96
Continuity of HIV-related medical care, New York City, 2005-2009: Do patients who initiate care stay in care? AIDS Patient Care STDS (2011) 1.87
A qualitative study of the barriers and facilitators to retention-in-care among HIV-positive women in the rural southeastern United States: implications for targeted interventions. AIDS Patient Care STDS (2010) 1.81
Effect of early syphilis infection on plasma viral load and CD4 cell count in human immunodeficiency virus-infected men: results from the FHDH-ANRS CO4 cohort. Arch Intern Med (2012) 1.77
Probability of HIV transmission during acute infection in Rakai, Uganda. AIDS Behav (2007) 1.76
Harm reduction theory: users' culture, micro-social indigenous harm reduction, and the self-organization and outside-organizing of users' groups. Int J Drug Policy (2006) 1.74
Current strategies for improving access and adherence to antiretroviral therapies in resource-limited settings. HIV AIDS (Auckl) (2013) 1.68
Risk network structure in the early epidemic phase of HIV transmission in Colorado Springs. Sex Transm Infect (2002) 1.66
Expanding access to HIV antiretroviral therapy among marginalized populations in the developed world. AIDS (2003) 1.63
Theorizing "Big Events" as a potential risk environment for drug use, drug-related harm and HIV epidemic outbreaks. Int J Drug Policy (2008) 1.61
Some data-driven reflections on priorities in AIDS network research. AIDS Behav (2007) 1.60
A dynamic social systems model for considering structural factors in HIV prevention and detection. AIDS Behav (2010) 1.60
Barriers to access to antiretroviral treatment in Mozambique, as perceived by patients and health workers in urban and rural settings. AIDS Patient Care STDS (2009) 1.53
Transforming social structures and environments to help in HIV prevention. Health Aff (Millwood) (2009) 1.51
Longitudinal changes in engagement in care and viral suppression for HIV-infected injection drug users. AIDS (2013) 1.49
The impact of retention in early HIV medical care on viro-immunological parameters and survival: a statewide study. AIDS Res Hum Retroviruses (2011) 1.46
A systematic review of antiretroviral adherence interventions for HIV-infected people who use drugs. Curr HIV/AIDS Rep (2012) 1.37
Combination prevention: new hope for stopping the epidemic. Curr HIV/AIDS Rep (2013) 1.36
Barriers to care among people living with HIV in South Africa: contrasts between patient and healthcare provider perspectives. AIDS Care (2012) 1.35
What do men who serve as lay health advisers really do?: Immigrant Latino men share their experiences as Navegantes to prevent HIV. AIDS Educ Prev (2009) 1.32
Structural and environmental HIV prevention for gay and bisexual men. AIDS (2000) 1.25
Factors influencing adherence to antiretroviral treatment in Asian developing countries: a systematic review. Trop Med Int Health (2011) 1.24
Harnessing the power of social networks to reduce HIV risk. Focus (2005) 1.23
Plasma HIV viral rebound following protocol-indicated cessation of ART commenced in primary and chronic HIV infection. PLoS One (2012) 1.22
Economic crisis, restrictive policies, and the population's health and health care: the Greek case. Am J Public Health (2013) 1.21
Factors contributing to dropping out from and returning to HIV treatment in an inner city primary care HIV clinic in the United States. AIDS Care (2013) 1.18
Theory, measurement and hard times: some issues for HIV/AIDS research. AIDS Behav (2013) 1.17
Interventions to promote linkage to and utilization of HIV medical care among HIV-diagnosed persons: a qualitative systematic review, 1996-2011. AIDS Behav (2013) 1.16
Linking and retaining HIV patients in care: the importance of provider attitudes and behaviors. AIDS Patient Care STDS (2013) 1.15
Integrated behavioral intervention to improve HIV/AIDS treatment adherence and reduce HIV transmission. Am J Public Health (2011) 1.14
Using community-based participatory research (CBPR) to develop a community-level HIV prevention intervention for Latinas: a local response to a global challenge. Womens Health Issues (2012) 1.11
The effect of antiretroviral treatment of different durations in primary HIV infection. AIDS (2008) 1.11
Adherence to antiretroviral therapy: factors independently associated with reported difficulty taking antiretroviral therapy in a national sample of HIV-positive Australians. HIV Med (2011) 1.08
Consistent condom use in relationships between seropositive injecting drug users and sex partners who do not inject drugs. AIDS (1994) 1.05
HIV vaccine knowledge and beliefs among communities at elevated risk: conspiracies, questions and confusion. J Natl Med Assoc (2005) 1.05
Preliminary support for the construct of health care empowerment in the context of treatment for human immunodeficiency virus. Patient Prefer Adherence (2012) 1.02
Homelessness and Other Risk Factors for HIV Infection in the Current Outbreak Among Injection Drug Users in Athens, Greece. Am J Public Health (2015) 1.01
Changing healthcare professionals' behaviors to eliminate disparities in healthcare: What do we know? How might we proceed? Am J Manag Care (2004) 1.01
Impact of highly active antiretroviral therapy on the molecular epidemiology of newly diagnosed HIV infections. AIDS (2012) 1.00
Focus on increasing treatment self-efficacy to improve human immunodeficiency virus treatment adherence. J Nurs Scholarsh (2012) 0.98
Task shifting of HIV management from doctors to nurses in Africa: clinical outcomes and evidence on nurse self-efficacy and job satisfaction. AIDS Care (2013) 0.97
HIV health center affiliation networks of black men who have sex with men: disentangling fragmented patterns of HIV prevention service utilization. Sex Transm Dis (2012) 0.96
HIV transmissions during seroconversion contribute significantly to new infections in men who have sex with men in Australia. AIDS Res Hum Retroviruses (2011) 0.95
Barriers to care for rural people living with HIV: a review of domestic research and health care models. J Assoc Nurses AIDS Care (2013) 0.94
Network Firewall Dynamics and the Subsaturation Stabilization of HIV. Discrete Dyn Nat Soc (2013) 0.88
Staff affirmations and client criticisms: staff and client perceptions of quality of care at sexually transmitted disease clinics. Sex Transm Dis (2005) 0.88
Adults receiving HIV care before the start of antiretroviral therapy in sub-Saharan Africa: patient outcomes and associated risk factors. J Acquir Immune Defic Syndr (2013) 0.87
Vaccines in the public eye. Nat Med (2005) 0.87
Using concept mapping to explore why patients become lost to follow up from an antiretroviral therapy program in the Zomba District of Malawi. BMC Health Serv Res (2013) 0.84
What experienced HIV-infected lay peer educators working in Midwestern U.S. HIV medical care settings think about their role and contributions to patient care. AIDS Patient Care STDS (2013) 0.84
Programs that incorporate active drug users as change agents for promoting their own goals and those of public health. Preface. Subst Use Misuse (2012) 0.81
Society, drug injectors, and AIDS. J Health Care Poor Underserved (1992) 0.79
Therapeutic ethics and communities at risk in the presence of potential mutation to resistant strains to HIV antiviral medications. AIDS (1998) 0.76
Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management. J Infect Dis (2005) 3.52
Care of patients with hepatitis C and HIV co-infection. AIDS (2004) 3.46
Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection: exploratory analyses from the SMART trial. Antivir Ther (2008) 2.93
Transmission of drug-resistant HIV-1 is stabilizing in Europe. J Infect Dis (2009) 2.60
Increasing prevalence of HIV-1 subtype A in Greece: estimating epidemic history and origin. J Infect Dis (2007) 2.21
Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems. Antimicrob Agents Chemother (2014) 2.18
Impact of hepatitis B virus infection on the progression of AIDS and mortality in HIV-infected individuals: a cohort study and meta-analysis. Clin Infect Dis (2009) 2.13
Prospective observational study of the impact of VIM-1 metallo-beta-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections. Antimicrob Agents Chemother (2009) 2.12
Economic recession and emergence of an HIV-1 outbreak among drug injectors in Athens metropolitan area: a longitudinal study. PLoS One (2013) 2.06
The global spread of hepatitis C virus 1a and 1b: a phylodynamic and phylogeographic analysis. PLoS Med (2009) 2.06
HBV viremia in newborns of HBsAg(+) predominantly Caucasian HBeAg(-) mothers. J Clin Virol (2010) 2.04
Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel. AIDS (2007) 2.00
Predicted effects of treatment for HCV infection vary among European countries. Gastroenterology (2012) 1.89
Melanocortin receptor-1 gene polymorphisms and the risk of cutaneous melanoma in a low-risk southern European population. J Invest Dermatol (2006) 1.80
Changes over calendar time in the risk of specific first AIDS-defining events following HIV seroconversion, adjusting for competing risks. Int J Epidemiol (2002) 1.79
End-stage liver disease in persons with hemophilia and transfusion-associated infections. Blood (2002) 1.73
HIV prevention interventions to reduce racial disparities in the United States: a systematic review. J Gen Intern Med (2012) 1.72
Management of antiviral resistance in patients with chronic hepatitis B. Antivir Ther (2004) 1.72
Risk of cancers during interrupted antiretroviral therapy in the SMART study. AIDS (2007) 1.72
Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized approach. Gastroenterology (2007) 1.72
Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach. Retrovirology (2009) 1.58
CD4 cell count and the risk of AIDS or death in HIV-Infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE. PLoS Med (2012) 1.54
Contact with HIV prevention programmes & willingness for new interventions among truckers in India. Indian J Med Res (2013) 1.51
Persistent HIV-1 infection of natural killer cells in patients receiving highly active antiretroviral therapy. Proc Natl Acad Sci U S A (2002) 1.49
European recommendations for the clinical use of HIV drug resistance testing: 2011 update. AIDS Rev (2011) 1.38
Differences in HIV RNA levels before the initiation of antiretroviral therapy among 1864 individuals with known HIV-1 seroconversion dates. AIDS (2004) 1.38
Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV-HCV International Panel. AIDS (2002) 1.30
The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes. J Acquir Immune Defic Syndr (2006) 1.27
Role of combination antiviral therapy in pandemic influenza and stockpiling implications. BMJ (2007) 1.22
Assessing the impact of biomedical research in academic institutions of disparate sizes. BMC Med Res Methodol (2009) 1.21
Dating the origin and dispersal of hepatitis B virus infection in humans and primates. Hepatology (2013) 1.19
Investigation of SEN virus infection in patients with cryptogenic acute liver failure, hepatitis-associated aplastic anemia, or acute and chronic non-A-E hepatitis. J Infect Dis (2003) 1.18
Theory, measurement and hard times: some issues for HIV/AIDS research. AIDS Behav (2013) 1.17
HIV‑1 molecular epidemiology in the Balkans: a melting pot for high genetic diversity. AIDS Rev (2012) 1.16
Outputs and cost of HIV prevention programmes for truck drivers in Andhra Pradesh, India. BMC Health Serv Res (2009) 1.14
Characterization of a novel vpu-harboring simian immunodeficiency virus from a Dent's Mona monkey (Cercopithecus mona denti). J Virol (2005) 1.13
Triple-class virologic failure in HIV-infected patients undergoing antiretroviral therapy for up to 10 years. Arch Intern Med (2010) 1.12
In vivo characteristics of human immunodeficiency virus type 1 intersubtype recombination: determination of hot spots and correlation with sequence similarity. J Gen Virol (2003) 1.09
Biological Warfare Plan in the 17th Century—the Siege of Candia, 1648–1669. Emerg Infect Dis (2015) 1.09
Impact of HIV-1 subtype on CD4 count at HIV seroconversion, rate of decline, and viral load set point in European seroconverter cohorts. Clin Infect Dis (2012) 1.09
The effectiveness of a 9-month regimen of isoniazid alone versus 3- and 4-month regimens of isoniazid plus rifampin for treatment of latent tuberculosis infection in children: results of an 11-year randomized study. Clin Infect Dis (2007) 1.07
The impact of the heptavalent pneumococcal conjugate vaccine on the epidemiology of acute otitis media complicated by otorrhea. Pediatr Infect Dis J (2011) 1.07
Integrating phylodynamics and epidemiology to estimate transmission diversity in viral epidemics. PLoS Comput Biol (2013) 1.07
Can statin therapy reduce the risk of melanoma? A meta-analysis of randomized controlled trials. Eur J Epidemiol (2009) 1.05
Phylogenetic reconstruction of a known HIV-1 CRF04_cpx transmission network using maximum likelihood and Bayesian methods. J Mol Evol (2004) 1.03
Limited cross-border infections in patients newly diagnosed with HIV in Europe. Retrovirology (2013) 1.01
Homelessness and Other Risk Factors for HIV Infection in the Current Outbreak Among Injection Drug Users in Athens, Greece. Am J Public Health (2015) 1.01
HIV Infection, Genital Symptoms and Sexual Risk Behavior among Indian Truck Drivers from a Large Transportation Company in South India. J Glob Infect Dis (2009) 1.01
Disclosure and concealment of sexual orientation and the mental health of non-gay-identified, behaviorally bisexual men. J Consult Clin Psychol (2012) 0.99
Molecular characterization of occult hepatitis B cases in Greek blood donors. J Med Virol (2009) 0.97
Activity of plazomicin (ACHN-490) against MDR clinical isolates of Klebsiella pneumoniae, Escherichia coli, and Enterobacter spp. from Athens, Greece. J Chemother (2012) 0.96
Viral proteins originated de novo by overprinting can be identified by codon usage: application to the "gene nursery" of Deltaretroviruses. PLoS Comput Biol (2013) 0.96
Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe. BMC Infect Dis (2014) 0.96
Financial crisis, austerity, and health in Europe. Lancet (2013) 0.95
Structural bridging network position is associated with HIV status in a younger Black men who have sex with men epidemic. AIDS Behav (2014) 0.94
Big Events in Greece and HIV Infection Among People Who Inject Drugs. Subst Use Misuse (2015) 0.94
The course of hepatitis C virus infection in pretransplantation anti-hepatitis C virus-negative renal transplant recipients: a retrospective follow-up study. Am J Kidney Dis (2006) 0.93
Prevention case management improves socioeconomic standing and reduces symptoms of psychological and emotional distress among transgender women. AIDS Care (2012) 0.93
Vitamin D insufficiency may impair CD4 recovery among Women's Interagency HIV Study participants with advanced disease on HAART. AIDS (2013) 0.92
Evolutionary analysis of hepatitis C virus gene sequences from 1953. Philos Trans R Soc Lond B Biol Sci (2013) 0.92
Statins and reduced risk of hepatocellular carcinoma in patients with hepatitis C virus infection: further evidence is warranted. J Clin Oncol (2013) 0.92
Reaching and engaging non-gay identified, non-disclosing Black men who have sex with both men and women. Cult Health Sex (2012) 0.92
Systematic review of racial disparities in human papillomavirus-associated anal dysplasia and anal cancer among men who have sex with men. Am J Public Health (2015) 0.91
Association of clinical progression in classic Kaposi's sarcoma with reduction of peripheral B lymphocytes and partial increase in serum immune activation markers. Arch Dermatol (2005) 0.91
Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients. Retrovirology (2012) 0.91
Risk associations of melanoma in a Southern European population: results of a case/control study. Cancer Causes Control (2008) 0.90
Genetic variants in immunoregulatory genes and risk for childhood lymphomas. Eur J Haematol (2009) 0.89
Transmission dynamics of carbapenemase-producing Klebsiella pneumoniae and anticipated impact of infection control strategies in a surgical unit. PLoS One (2012) 0.89